QQ客服 官方微博 反馈留言

	A novel anti-rheumatic drug, iguratimod for RA - an initial clinical trial
	Xiao, Feng; Zhang, Ling-ling; Wei, Wei; Xu, Jian-hua; Li, Xing-fu; Li, Xiang-pei; Zhang, Miu-jia; Deng, Jin-su; Hu, Shao-xian; Zhang 更多
刊名	ACTA PHARMACOLOGICA SINICA
	2013
卷号	34页码:41-42
关键词	iguratimod rheumatoid arthritis selective COX-2 inhibitors clinical trial
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5159545
专题	山东大学
作者单位	Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Minist Ed
推荐引用方式 GB/T 7714	Xiao, Feng,Zhang, Ling-ling,Wei, Wei,et al. A novel anti-rheumatic drug, iguratimod for RA - an initial clinical trial[J]. ACTA PHARMACOLOGICA SINICA,2013,34:41-42.
APA	Xiao, Feng.,Zhang, Ling-ling.,Wei, Wei.,Xu, Jian-hua.,Li, Xing-fu.,...&Zhang 更多.(2013).A novel anti-rheumatic drug, iguratimod for RA - an initial clinical trial.ACTA PHARMACOLOGICA SINICA,34,41-42.
MLA	Xiao, Feng,et al."A novel anti-rheumatic drug, iguratimod for RA - an initial clinical trial".ACTA PHARMACOLOGICA SINICA 34(2013):41-42.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。